Mpm Bioventures 2014 Gp Llc
10% Owner at Werewolf Therapeutics, Inc. (HOWL); 10% Owner at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $797K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | TRDAEntrada Therapeutics, Inc. | Sell | 29,0884,202,346 held (−1%) | $7.06 | $205K | -19.7% |
| Sep 3SEC | TRDAEntrada Therapeutics, Inc. | Sell | 25,1314,177,215 held (−1%) | $7.19 | $181K | -21.1% |
| Sep 3SEC | TRDAEntrada Therapeutics, Inc. | Sell | 32,2634,144,952 held (−1%) | $7.17 | $231K | -20.9% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 64,3315,257,105 held (−1%) | $0.83 | $53K | +18.1% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 88,8025,168,303 held (−2%) | $0.98 | $87K | +0.0% |
| Nov 25SEC | HOWLWerewolf Therapeutics, Inc. | Sell Plan | 42,5335,125,770 held (−1%) | $0.92 | $39K | +6.5% |
- Sell
10% Owner Mpm Bioventures 2014 Gp Llc sold $53K of HOWL at $0.83 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Mpm Bioventures 2014 Gp Llc sold $87K of HOWL at $0.98 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Mpm Bioventures 2014 Gp Llc sold $39K of HOWL at $0.92 — pre-scheduled 10b5-1 plan sale.